On this page
FSSAI crackdown sends Dabur, Diageo and energy-drink brands back to label review
Our read
Quick-commerce platforms turn FSSAI enforcement into a de facto assortment filter, accelerating a wider reset of health and stimulant claims across Indian FMCG.
For operators
Audit FMCG assortments and supplier documentation now, as non-compliant health, nutrition and stimulant claims could trigger delistings, relabeling delays and lost sales within the 90-day window.
Watch
FSSAI publishes product-specific notices, penalties, recall orders or a list of non-compliant claims.
The report,
FSSAI’s tougher enforcement of existing labeling and product-claim standards is forcing Indian consumer-goods and liquor companies to review packaging and advertising. Dabur and Diageo have challenged actions, while Blinkit may delist affected Dabur products and energy-drink brands face 90-day changes.
One email each morning: the day’s top moves in Indian retail, why each matters and what to watch. Free. Stop any time.
Reported figures
From the report. Source details below
| 70-80 mg caffeine per | 250 ml |
|---|---|
| 10-15% regulatory framework in | 2016 |
| nearly 90% of regulations in place by | 2020 |
Also in the report
- Rs 13,000 crore beverage category
Why it matters for the brand
Build regulatory-claims diligence into FMCG deal screens, prioritizing targets with substantiated labeling, adaptable packaging supply chains and limited exposure to enforcement-sensitive product claims.
What to track next
- Blinkit begins delisting Dabur or other named-brand SKUs, or competitors adopt similar seller-document requirements.
- Energy-drink brands announce label changes, reformulations, revised caffeine disclosures or paused campaigns before the compliance deadline.
- Consumer complaints, court petitions or ASCI rulings challenge wellness and stimulant advertising.
- Retailer search rankings, sponsored listings or conversion rates fall for affected products despite continued availability.
- FSSAI extends scrutiny to supplements, ayurvedic products, malted drinks, protein foods or alcohol advertising.
Likely next moves
Our read of what comes next — analysis, not reported by the source.
- Audit all packaging, product pages, ad creatives and influencer scripts for health, nutrition, stimulant, immunity, therapeutic and comparative claims.
- Prioritize compliant replacement labels for high-velocity quick-commerce SKUs before the 90-day deadline.
- Secure written compliance documentation and updated label assets for Blinkit, Zepto, Swiggy Instamart, Amazon and modern-trade partners.
- Build inventory-transition plans to avoid stranded non-compliant packaging, including region-by-region depletion and relabelling options.
- Shift near-term marketing toward taste, occasion, provenance and lifestyle messaging where health claims require substantiation or qualification.
Show 1 more
- Increase regulatory review of alcohol, energy-drink and functional-food campaigns, especially content that can be interpreted as targeting minors or implying performance benefits.
The counter-case
The case against this reading — not reported by the source.
This may be a limited, short-term compliance event rather than a material earnings risk. Large brands typically have regulatory, legal and packaging-change capacity, and reformulation or relabelling costs are unlikely to be significant relative to sales. A 90-day transition window reduces immediate disruption, while any Blinkit delisting could be temporary and confined to specific SKUs rather than a broad sales-channel loss. Tougher enforcement may also favor established companies by raising compliance burdens for smaller rivals.
The source
Published
First seen